Sanara Medtech Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.6% | -4.8% | -8.6% | -7.0% | 9.5% | 3.5% | -8.5% | 10.3% | 8.3% | 14.3% | -8.9% | 7.2% | 5.2% | |
| 6.2% | 6.2% | 6.0% | 6.0% | 5.1% | 6.1% | 4.8% | 4.6% | 2.3% | 93.1% | 2.1% | 2.2% | 25.0% | |
| 5.4% | 4.9% | 4.3% | 7.0% | 4.7% | 4.5% | 5.6% | 5.6% | 4.7% | -7.3% | 3.7% | 5.3% | 1.6% | |
| 3.5% | -3.8% | -10.6% | -3.6% | 8.4% | 1.3% | -10.1% | 5.1% | 8.7% | -18.3% | -19.8% | -2.0% | -8.0% | |
| 1.1% | 0.3% | 0.4% | 0.3% | 0.0% | 0.4% | 7.4% | 6.8% | 4.0% | 0.3% | 0.2% | 0.0% | 1.1% | |
| -63.1% | -0.3% | -0.4% | -0.3% | -29.3% | -0.5% | -22.1% | -15.2% | -13.0% | -8.9% | -0.2% | 0.0% | -5.4% | |
| – | -0.7% | – | – | – | – | – | – | – | – | – | -0.5% | – | |
| – | – | – | – | 70.3% | 0.0% | 51.5% | -6.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 57.6% | -1.1% | -3.6% | 23.8% | 66.6% | -4.6% | 51.2% | -9.5% | -2.9% | 0.5% | -1.7% | -0.7% | -1.2% | |
| 1.1% | -6.2% | -12.5% | 16.5% | 46.7% | -1.5% | 20.5% | -14.4% | -7.7% | 6.0% | -10.7% | 6.5% | -1.4% | |
| 5.6% | -5.1% | -9.0% | -7.3% | 9.4% | 3.2% | -15.9% | 3.5% | 4.2% | 14.0% | -9.0% | 7.2% | 4.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.